Biosimilars Global Market Opportunities And Strategies To 2031

Jul 2022| TBR771E| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Monoclonal Antibodies; Insulin; Erythropoietin; Granulocyte-Colony Stimulating Factor; Other Hormones
2) By Application: Oncology; Chronic And Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases
Covering: Amgen; Pfizer; Novartis AG; Samsung Bioepis Co., Ltd.; Viatris

Biosimilars Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biosimilars market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest growing market for biosimilars? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biosimilars market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider biosimilars market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about biosimilars market.
  • Key Trends - Highlights the major trends shaping the global biosimilars market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region.
  • Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by type, and by applications in the market.
  • Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Pipeline Analysis - Briefs on the pipeline analysis of biosimilars from the major players in the market.
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - Includes recommendations for biosimilars providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Type: Monoclonal Antibodies; Insulin; Erythropoietin; Granulocyte-Colony Stimulating Factor; Other Hormones; Other Types
  • By Application: Oncology; Chronic And Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases; Other Applications

Companies Mentioned: Amgen; Pfizer; Novartis AG; Samsung Bioepis Co., Ltd.; Viatris

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biosimilars indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 2 : Global Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3 : Global Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4 : Global Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5 : Global Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6 : Global Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7 : Global Biosimilars Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8 : Global Biosimilars Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9 : Global Biosimilars Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10 : Global Biosimilars Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11 : Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
  • Table 12 : Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
  • Table 13 : Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 14 : Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 15 : Asia-Pacific, Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 16 : Asia-Pacific Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 17 : Asia-Pacific Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 18 : Asia-Pacific Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 19 : Asia-Pacific Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 20 : Asia-Pacific Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 21 : Asia-Pacific Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 22 : China Population By Age Group, 2016-2026, Thousands
  • Table 23 : China GDP Per Capita, 2016-2021, $
  • Table 24 : China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 25 : China Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 26 : China Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 27 : China Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 28 : China Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 29 : China Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 30 : China Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 31 : China Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 32 : India Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 33 : India Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 34 : India Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 35 : India Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 36 : India Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 37 : India Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 38 : Japan Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 39 : Japan Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 40 : Japan Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 41 : Japan Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 42 : Japan Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 43 : Japan Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 44 : Australia Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 45 : Australia Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 46 : Australia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 47 : Australia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 48 : Australia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 49 : Australia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 50 : Indonesia Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 51 : Indonesia Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 52 : Indonesia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 53 : Indonesia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 54 : Indonesia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 55 : Indonesia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 56 : South Korea Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 57 : South Korea Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 58 : South Korea Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 59 : South Korea Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 60 : South Korea Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 61 : South Korea Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 62 : Western Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 63 : Western Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 64 : Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 65 : Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 66 : Western Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 67 : Western Europe Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 68 : Western Europe Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 69 : Western Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 70 : Western Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 71 : Western Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 72 : Western Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 73 : UK Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 74 : UK Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 75 : UK Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 76 : UK Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 77 : UK Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 78 : UK Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 79 : Germany Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 80 : Germany Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 81 : Germany Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 82 : Germany Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 83 : Germany Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 84 : Germany Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 85 : France Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 86 : France Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 87 : France Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 88 : France Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 89 : France Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 90 : France Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 91 : Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 92 : Eastern Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 93 : Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 94 : Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 95 : Eastern Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 96 : Eastern Europe Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 97 : Eastern Europe Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 98 : Eastern Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 99 : Eastern Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 100 : Eastern Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 101 : Eastern Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 102 : Russia Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 103 : Russia Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 104 : Russia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 105 : Russia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 106 : Russia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 107 : Russia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 108 : North America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 109 : North America GDP Per Capita, By Country, 2016-2021, $
  • Table 110 : North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 111 : North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 112 : North America Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 113 : North America Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 114 : North America Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 115 : North America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 116 : North America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 117 : North America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 118 : North America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 119 : USA Population By Age Group, 2016-2026, Thousands
  • Table 120 : USA GDP Per Capita, 2016-2021, $
  • Table 121 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 122 : USA Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 123 : USA Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 124 : USA Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 125 : USA Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 126 : USA Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 127 : USA Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 128 : USA Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 129 : South America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 130 : South America GDP Per Capita, By Country, 2016-2021, $
  • Table 131 : South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 132 : South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 133 : South America Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 134 : South America Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 135 : South America Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 136 : South America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 137 : South America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 138 : South America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 139 : South America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 140 : Brazil Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 141 : Brazil Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 142 : Brazil Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 143 : Brazil Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 144 : Brazil Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 145 : Brazil Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 146 : Middle East Population By Age Group, By Country, 2016-2026, Thousands
  • Table 147 : Middle East GDP Per Capita, By Country, 2016-2021, $
  • Table 148 : Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 149 : Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 150 : Middle East Healthcare Services Market Size, 2016-2021, $ Billion
  • Table 151 : Middle East Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 152 : Middle East Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 153 : Middle East Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 154 : Middle East Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 155 : Middle East Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 156 : Middle East Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 157 : Africa Population By Age Group, By Country, 2016-2026, Thousands
  • Table 158 : Africa GDP Per Capita, By Country, 2016-2021, $
  • Table 159 : Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 160 : Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 161 : Africa Healthcare Services Market Size, 2016-2021, $ Billion
  • Table 162 : Africa Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Table 163 : Africa Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 164 : Africa Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 165 : Africa Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 166 : Africa Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 167 : Africa Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 168 : Global Smart Wearables Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Table 169 : Amgen Inc. – Financial Overview, 2017 - 2021, $ Billion
  • Table 170 : Pfizer Inc. – Financial Overview, 2017 - 2021, $ Billion
  • Table 171 : Novartis AG – Financial Overview, 2017 - 2021, $ Billion
  • Table 172 : Viatris Inc. – Financial Overview, 2017 - 2021, $ Billion
  • Table 173 : Global Biosimilars Market, Pipeline Analysis
  • Table 174 : Global Biosimilars Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 175 : Global Biosimilars Market Size Gain ($ Million), Segmentation By Type, 2021 – 2026
  • Table 176 : Global Biosimilars Market Size Gain ($ Million), Segmentation By Application, 2021 – 2026
  • Table 177 : Biosimilars Market Data Sources
  • Figure 1 : Geographic Regions Covered
  • Figure 2 : Global Biosimilars Market Segmentation By Type
  • Figure 3 : Global Biosimilars Market Segmentation By Application
  • Figure 4 : Global Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 5 : Global Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 6 : Global Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 7 : Global Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 8 : Global Biosimilars Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 9 : Global Biosimilars Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 10 : Asia-Pacific Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 11 : Asia-Pacific Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 12 : Asia-Pacific Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 13 : Asia-Pacific Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 14 : China Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 15 : China Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 16 : China Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 17 : China Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 18 : India Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 19 : India Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 20 : India Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 21 : India Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 22 : Japan Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 23 : Japan Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 24 : Japan Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 25 : Japan Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 26 : Australia Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 27 : Australia Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 28 : Australia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 29 : Australia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 30 : Indonesia Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 31 : Indonesia Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 32 : Indonesia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 33 : Indonesia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 34 : South Korea Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 35 : South Korea Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 36 : South Korea Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 37 : South Korea Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 38 : Western Europe Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 39 : Western Europe Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 40 : Western Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 41 : Western Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 42 : UK Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 43 : UK Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 44 : UK Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 45 : UK Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 46 : Germany Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 47 : Germany Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 48 : Germany Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 49 : Germany Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 50 : France Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 51 : France Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 52 : France Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 53 : France Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 54 : Eastern Europe Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 55 : Eastern Europe Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 56 : Eastern Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 57 : Eastern Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 58 : Russia Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 59 : Russia Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 60 : Russia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 61 : Russia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 62 : North America Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 63 : North America Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 64 : North America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 65 : North America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 66 : USA Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 67 : USA Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 68 : USA Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 69 : USA Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 70 : South America Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 71 : South America Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 72 : South America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 73 : South America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 74 : Brazil Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 75 : Brazil Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 76 : Brazil Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 77 : Brazil Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 78 : Middle East Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 79 : Middle East Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 80 : Middle East Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 81 : Middle East Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 82 : Africa Biosimilars Market, Historic, 2016 – 2021, $ Million
  • Figure 83 : Africa Biosimilars Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 84 : Africa Biosimilars Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 85 : Africa Biosimilars Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 86 : Global biosimilars Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Figure 87 : Amgen Inc. – Financial Overview, 2017 – 2021, $ Billion
  • Figure 88 : Pfizer Inc. – Financial Overview, 2017 – 2021, $ Billion
  • Figure 89 : Novartis AG – Financial Overview, 2017 – 2021, $ Billion
  • Figure 90 : Viatris Inc. – Financial Overview, 2017 – 2021, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

  • Date - Jun 2022
  • Code - TBR771D

Including: 1) By Type: Monoclonal Antibodies; Insulin; Erythropoietin; Granulocyte-Colony Stimulating Factor; Other Hormone; Others
2) By Application: Oncology; Chronic And Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases; Others
Covering: Amgen; Pfizer; Novartis AG; Viatris; Celltrion, Inc.

Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research Company provides the strategists; marketers and senior management ...

Biosimilars Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR771C

Including: 1) By Product: Recombinant Non-glycosylated Proteins; Recombinant Glycosylated Proteins
2) By Types: Human Growth Hormone; Erythropoietin; Monoclonal antibodies; Insulin; Interferon; Granulocyte-Colony Stimulating Factor; Others
3) By Application: Oncology; Chronic and Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases; Others
Covering: Pfizer; Amgen; Biocon; Celltrion; Dr. Reddy's Laboratories; Boehringer Ingelheim; Elli Lilly and Company; Mylan N.V.

Biosimilars Global ...

Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030

  • Date - Sep 2021
  • Code - TBR771B

Including: 1) By Product: Recombinant Non-glycosylated Proteins; Recombinant Glycosylated Proteins
2) By Types: Human Growth Hormone; Erythropoietin; Monoclonal antibodies; Insulin; Interferon; Granulocyte-Colony Stimulating Factor; Others
3) By Application: Oncology; Chronic and Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases; Others
Covering: Pfizer; Amgen; Biocon; Celltrion; Dr. Reddy's Laboratories

Biosimilars Global Market Report 2021: COVID-19 Growth And Change to ...

Biosimilars Market Global Report 2020-30

  • Date - Apr 2020
  • Code - TBR771A

Including: 1) By Product: Recombinant Non-glycosylated Proteins; Recombinant Glycosylated Proteins; 2) By Types: Human Growth Hormone; Erythropoietin; Monoclonal antibodies; Insulin; Interferon; Granulocyte-Colony Stimulating Factor; Others; 3) By Application: Oncology; Chronic and Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases; Others

Covering: Pfizer; Amgen; Biocon; Celltrion; Dr. Reddy's Laboratories

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS